CRCL With CRCL's markets relatively unproven, outcomes vary widely; SUSQ recommends waiting for a better entry point and maintain its $69 PT

CRCL With CRCL's markets relatively unproven, outcomes vary widely; SUSQ recommends waiting for a better entry point and maintain its $69 PT @ SUSQ